These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33755654)

  • 1. Oliceridine (Olinvyk) - a new opioid for severe pain.
    Med Lett Drugs Ther; 2021 Mar; 63(1619):37-39. PubMed ID: 33755654
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain.
    Ayad S; Demitrack MA; Burt DA; Michalsky C; Wase L; Fossler MJ; Khanna AK
    Clin Drug Investig; 2020 Aug; 40(8):755-764. PubMed ID: 32583295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers.
    Soergel DG; Subach RA; Burnham N; Lark MW; James IE; Sadler BM; Skobieranda F; Violin JD; Webster LR
    Pain; 2014 Sep; 155(9):1829-1835. PubMed ID: 24954166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oliceridine, a G protein-selective ligand at the μ-opioid receptor, for the management of moderate to severe acute pain.
    Gan TJ; Wase L
    Drugs Today (Barc); 2020 Apr; 56(4):269-286. PubMed ID: 32309822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain.
    Tan HS; Habib AS
    Expert Opin Drug Saf; 2021 Nov; 20(11):1291-1298. PubMed ID: 34370562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utilization of Mu-Opioid Receptor Biased Agonists: Oliceridine, an Opioid Analgesic with Reduced Adverse Effects.
    Urits I; Viswanath O; Orhurhu V; Gress K; Charipova K; Kaye AD; Ngo A
    Curr Pain Headache Rep; 2019 Mar; 23(5):31. PubMed ID: 30880365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oliceridine: First Approval.
    Markham A
    Drugs; 2020 Nov; 80(16):1739-1744. PubMed ID: 33025536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis.
    Bergese S; Berkowitz R; Rider P; Ladouceur M; Griffith S; Segura Vasi A; Cochrane K; Wase L; Demitrack MA; Habib AS
    Pain Res Manag; 2020; 2020():7492865. PubMed ID: 33163127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults.
    Lambert D; Calo G
    Br J Anaesth; 2020 Dec; 125(6):e473-e474. PubMed ID: 33070948
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy, safety, and side effects of oliceridine in acute postoperative pain, a protocol for a systematic review and meta-analysis.
    Wolf A; Unterberg M; Witowski A; Adamzik M; Wolf A
    PLoS One; 2024; 19(2):e0299320. PubMed ID: 38422105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative pain.
    Azzam AAH; Lambert DG
    Expert Opin Drug Discov; 2022 Mar; 17(3):215-223. PubMed ID: 34817313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
    Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER
    Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical review of oliceridine injection as an IV opioid analgesic for the management of severe acute pain.
    Viscusi ER
    Expert Rev Neurother; 2022 Jun; 22(6):419-426. PubMed ID: 35502668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods.
    Biskupiak J; Oderda G; Brixner D; Wandstrat TL
    J Comp Eff Res; 2024 May; 13(5):e230041. PubMed ID: 38497192
    [No Abstract]   [Full Text] [Related]  

  • 15. Oliceridine, a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic Model.
    Fossler MJ; Sadler BM; Farrell C; Burt DA; Pitsiu M; Skobieranda F; Soergel DG
    J Clin Pharmacol; 2018 Jun; 58(6):762-770. PubMed ID: 29393971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oliceridine in the treatment of moderate to severe acute pain.
    Eleswarpu SS; Habib AS
    Pain Manag; 2021 May; 11(3):237-248. PubMed ID: 33455450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oliceridine (TRV130), a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model.
    Fossler MJ; Sadler BM; Farrell C; Burt DA; Pitsiu M; Skobieranda F; Soergel DG
    J Clin Pharmacol; 2018 Jun; 58(6):750-761. PubMed ID: 29412458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Biased' opioids could yield safer pain relief.
    Wadman M
    Science; 2017 Nov; 358(6365):847-848. PubMed ID: 29146784
    [No Abstract]   [Full Text] [Related]  

  • 19. Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events.
    Simpson KN; Fossler MJ; Wase L; Demitrack MA; Wandstrat TL
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):671-681. PubMed ID: 35129031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating oliceridine as a treatment option for moderate to severe acute post-operative pain in adults.
    Jin Z; Zhu M; Gupta A; Page C; Gan TJ; Bergese SD
    Expert Opin Pharmacother; 2022 Jan; 23(1):9-17. PubMed ID: 34534033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.